Abeona Therapeutics Inc vs American Superconductor Corporation — how do they compare? Abeona Therapeutics Inc trades at $7.49 (market cap $421.19M), while American Superconductor Corporation trades at $33.61 (market cap $1.56B). The key difference: American Superconductor Corporation is far larger — about 3.7× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, American Superconductor Corporation nearer its low. Which is the better fit depends on your goals.
| ABEO | AMSC | |
|---|---|---|
Market Cap | $421.19M | $1.56B |
Sector | Health | Technology |
52-Week High | $7.45 | $66.68 |
52-Week Low | $4.17 | $25.95 |
Enterprise Value | $276.10M | $1.42B |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →AMSC provides energy technology solutions for smarter and cleaner power grids. It offers wind turbine electronic controls and advanced grid systems that enhance the reliability and efficiency of renewable energy networks.
Read more on AMSC →